Skip to main content
Report this ad

See also:

Propanc stock surges on potential cancer treatment

Earlier this month, Propanc shared information regarding the anti-cancer effects of its PRP treatment with Cellular Oncology, a peer-reviewed journal of the International Society for Cellular Oncology.
Earlier this month, Propanc shared information regarding the anti-cancer effects of its PRP treatment with Cellular Oncology, a peer-reviewed journal of the International Society for Cellular Oncology.
Marv Dumon
Report this ad